Periodontal and glycemic effects of nonsurgical periodontal therapy in patients with type 2 diabetes stratified by baseline HbA1c

被引:35
|
作者
Kaur, Palka K. [1 ]
Narula, Satish C. [1 ]
Rajput, Rajesh [2 ]
Sharma, Rajinder K. [1 ]
Tewari, Shikha [1 ]
机构
[1] Post Grad Inst Dent Sci, Dept Periodont & Oral Implantol, Rohtak 124001, Haryana, India
[2] Post Grad Inst Dent Sci, Dept Med Unit & Endocrinol 7, Rohtak 124001, Haryana, India
关键词
type 2 diabetes mellitus; hemoglobin A; glycated; chronic periodontitis; METABOLIC-CONTROL; GLYCATED HEMOGLOBIN; SURFACE-AREA; MELLITUS; METAANALYSIS; OUTCOMES; DISEASE; ALPHA;
D O I
10.2334/josnusd.57.201
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
We evaluated the effects of nonsurgical periodontal therapy in 100 patients with type 2 diabetes and chronic periodontitis. The participants were classified as having good (n = 48) or poor (n = 52) glycemic control and were further randomly allocated to receive either scaling and root planning treatment group or no treatment (n = 50 each). The effect of nonsurgical periodontal therapy was compared among diabetic patients with good glycemic control, those with poor glycemic control, and 25 nondiabetic individuals. Periodontal and metabolic status was recorded at baseline, 3 months, and 6 months. In patients receiving treatment, periodontal parameters significantly improved and HbA(1c) decreased by 10.8%. Improvements in gingival index and bleeding on probing were greater in the nondiabetic participants and the treated patients with good glycemic control than in the treated patients with poor glycemic control (P < 0.05). Regression analysis showed that improvement in periodontal status was independently associated with glycemic improvement. Nonsurgical periodontal therapy improved glycemic control and periodontal health in patients with type 2 diabetes. However, patients with poor baseline glycemic control had less clinical improvement than did those without diabetes and those with good glycemic control.
引用
收藏
页码:201 / 211
页数:11
相关论文
共 50 条
  • [41] Effect of Nonsurgical Periodontal Therapy on Insulin Resistance in Patients with Type 2 Diabetes Mellitus and Chronic Periodontitis
    Chandni, Radhakrishnan
    Mammen, Jerry
    Joseraj, M. G.
    Joseph, Rosamma
    DIABETES, 2015, 64 : A692 - A692
  • [42] Effect of orlistat on insulin resistance in patients with type 2 diabetes with baseline HbA1c levels ≥8%
    Rissanen, A
    Hollander, P
    DIABETES, 2002, 51 : A413 - A413
  • [43] Type 2 diabetes and HbA1c goal: time for individualised therapy
    Jabbour, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) : 1409 - 1409
  • [44] Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy
    Wang, Jun-Sing
    Lee, I-Te
    Lee, Wen-Jane
    Lin, Shi-Dou
    Su, Shih-Li
    Tu, Shih-Te
    Tseng, Yao-Hsien
    Lin, Shih-Yi
    Sheu, Wayne Huey-Herng
    JOURNAL OF DIABETES, 2017, 9 (03) : 248 - 255
  • [45] Study on the Effects of Melatonin on Glycemic Control and Periodontal Parameters in Patients with Type II Diabetes Mellitus and Periodontal Disease
    Anton, Diana-Maria
    Martu, Maria-Alexandra
    Maris, Marius
    Maftei, George-Alexandru
    Sufaru, Irina-Georgeta
    Tatarciuc, Diana
    Luchian, Ionut
    Ioanid, Nicoleta
    Martu, Silvia
    MEDICINA-LITHUANIA, 2021, 57 (02): : 1 - 9
  • [46] GAP ANALYSIS OF OLDER ADULTS WITH TYPE 2 DIABETES RECEIVING NONSURGICAL PERIODONTAL THERAPY
    Obadan-Udoh, Enihomo
    Jordan, Samantha
    Mudah, Olubukola
    Borgnakke, Wenche
    Tavares, Mary
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2017, 17 (04) : 335 - 349
  • [47] A study on the change in HbA1c levels before and after non-surgical periodontal therapy in type-2 diabetes mellitus in generalized periodontitis
    Munjal, Akshay
    Jain, Yashika
    Kote, Sowmya
    Krishnan, Vineesh
    Fahim, Rafi
    Metha, Samruddhi Swapnil
    Passi, Deepak
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (04) : 1326 - 1329
  • [48] Liraglutide, a human GLP-1 analogue, substantially reduces HbA1c in subjects with type 2 diabetes, irrespective of HbA1c at baseline
    Vaag, A.
    Nauck, M. A.
    Brandle, M.
    Colagiuri, S.
    Schmitz, O.
    Zdravkovic, M.
    Hermansen, K.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S68 - S69
  • [49] COST OF ANTIHYPERGLYCEMIC THERAPY IN TYPE 2 DIABETES PATIENTS DEPENDING ON HBA1C AND BMI VALUES
    Sorg, A.
    Dombrowski, S.
    Kostev, K.
    VALUE IN HEALTH, 2016, 19 (07) : A665 - A665
  • [50] Seasonal variation in HbA1c in patients with Type 2 diabetes mellitus
    Carney, TA
    Guy, SP
    Helliwell, CD
    DIABETIC MEDICINE, 2000, 17 (07) : 554 - 555